HWC Form 4: Director Dean Liollio Adds 397.17 Shares via DRIP
Rhea-AI Filing Summary
Dean Liollio, a director of Hancock Whitney Corp (HWC), reported a purchase of common stock on 09/26/2025. The Form 4 shows an acquisition of 397.17 shares at a price of $63.26 per share, and states the total beneficial ownership following the transaction as 35,022.1504 shares held directly. The filing notes these shares include purchases made through the company’s Dividend Reinvestment Plan since the reporting person’s last Form 4. The Form 4 was signed on 09/30/2025 by Dean Liollio via power of attorney Kathryn Mistich.
Positive
- Director purchase disclosed: Acquisition of 397.17 shares demonstrates insider buying activity
- Direct beneficial ownership: 35,022.1504 shares held directly after transaction
- Includes DRIP activity: Filing clarifies shares include Dividend Reinvestment Plan purchases since last Form 4
- Properly executed: Form signed by reporting person via power of attorney on 09/30/2025
Negative
- None.
Insights
TL;DR: A small director purchase via dividend reinvestment increased direct holdings to 35,022.1504 shares.
The reported acquisition on 09/26/2025 is modest in size (397.17 shares) and executed at $63.26 per share, with the filing clarifying inclusion of Dividend Reinvestment Plan activity since the last Form 4. Because the ownership is recorded as direct, this reflects personal economic exposure rather than an indirect or derivative position. The transaction appears routine for insiders who participate in DRIPs; no options, dispositions, or derivative instruments are reported.
TL;DR: Routine insider share accumulation through DRIP, properly disclosed on Form 4 and signed by POA.
The filing identifies Dean Liollio as a director and indicates the Form 4 was executed by power of attorney on 09/30/2025. Disclosure includes transaction date, price, and resulting direct holdings, meeting standard Section 16 reporting elements. There are no amendments or additional relationship changes noted. The filing contains no indications of unusual or material corporate actions tied to this transaction.